Latest News
Conference Coverage
ATA risk stratification for DTC performs well in real-world cohort
NEW ORLEANS – The risk stratification system also worked well as a predictor of disease-specific survival.
Conference Coverage
No clear winner for treating neuropathic pain
PHILADELPHIA – More head-to-head trials of treatments for neuropathic pain are needed.
Feature
Cost gap widens between brand-name, generic drugs
Generics represent almost 90% of prescriptions filled in the United States but less than 25% of spending.
Video
Obeticholic acid reversed NASH liver fibrosis in phase 3 trial
VIENNA – Phase 3 trial results showed obeticholic acid, already FDA approved, is the first drug to reverse liver fibrosis in NASH patients.
News
Low LDL cholesterol may increase women’s risk of hemorrhagic stroke
Investigators found no association between HDL cholesterol and risk of hemorrhagic stroke or between total cholesterol and risk of hemorrhagic...
Latest News
Proportion of women speaking at medical conferences rises over decade
Though the proportion of female speakers at medical conferences has increased during the last decade, women continue to be underrepresented.
Feature
As Sanders officially revives Medicare-for-all, Plan B for Democrats gains traction
“Medicare for America” offers a more incremental approach.
Latest News
Bipartisanship breaks out at House hearing on insulin prices
Lawmakers on both sides of aisle grill insulin manufacturers, PBM leaders on the high cost of insulin.
Video
Intermittent, but prolonged, calorie restriction may improve metabolic markers
NEW ORLEANS – A clinical trial showed improved metabolic markers in patients who went on the diet, especially in those with higher risk.
Latest News
Oxytocin dampens the brain’s food-related reward circuitry
NEW ORLEANS – The decreased brain activation may underlie oxytocin’s promise as a weight-loss medication.
Conference Coverage
Alirocumab reduces both type 1 and 2 MIs
NEW ORLEANS – The ODYSSEY Outcomes trial provides first-ever evidence that lowering LDL prevents type 2 MI.